Sezzle [SEZL] - Last Close: $44.74
Stronger-then-expected Q1 earnings are rallying shares of Sezzle to the top of the charts in today’s premarket.
The company reported EPS of $1.34 per share, up from $0.31 per share a year earlier, and revenues grew 35.4% YoY to $46.98 million in Q1.
Consensus earnings & revenue estimates weren’t available for this stock, but shares are reacting favorably to the report.
SEZL is up 46.6%, but volume is thin at less than 50K shares traded.
My Take: SEZL is coming off a pullback, which may explain why this rally seems so exaggerated.
Zai Laboratory [ZLAB] - Last Close: $16.57
Strong earnings are also rallying shares of this China-based biotech stock.
Zai Labs reported a thinner-than-expected Q1 loss of $(0.55) per share against the Street’s $(0.94) estimate.
Revenues of $87.1 million also cleared the $75.24 million consensus estimate.
ZLAB is up 20.7% on roughly 100K shares traded.
My Take: ZLAB has been riding a long downtrend since the beginning of the year. However, it recently pivoted upward after bottoming out at around $14 per share. These results could help it extend its positive trend.
Pop Culture [CPOP] - Last Close: $1.70
The Chinese entertainment company released an interim financial report for the six months ending Dec. 31st, 2023.
Pop Culture’s revenues jumped 113% year-on-year and grew to $24 million for the period.
The company also managed to generate a gross profit of $1.78 million after posting a $2.34 million loss a year ago.
CPOP is today’s top mover with an 85.8% gain on more than 8 million shares traded.
My Take: I am always suspicious of these sudden explosive rallies in China stocks. I would steer clear of CPOP unless you have a contingency plan for when it inevitably reverses course.
Greenwave Tech [GWAV] - Last Close: $0.0581
Greenwave Tech is rallying after its CEO exchanged a $7.22 million debt for common shares of GWAV at a price of $0.1167 per share.
The move will improve the company’s balance sheet, and it demonstrates to the market that leadership has “skin in the game.”
The transaction price was also significantly higher than the stock’s current bid, implying that the stock could be undervalued at its current level.
GWAV is up 23.9%, and it’s this morning’s most active stock with over 37 million shares traded.
My Take: GWAV has had a really rough go of it over the past three months. I don’t think this insider transaction will be enough to move the needle in the long run.
